An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Southern California

About this trial

This study evaluates the cell and biomarkers associated with the aggressive behavior of cancer.

Eligibility criteria

Qualifiers

Diagnosis/disease status: New diagnosis of head and neck cancer

Allowable type and amount of prior therapy: No prior treatment

Age ≥ 18 years.

Ability to understand and the willingness to sign a written informed consent.

Disqualifiers

Patients who have had treatment of head and neck cancer

Trial design

Treatments tested in this trial

  • Non-Interventional Study

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Southern California

Lead sponsor

National Cancer Institute (NCI)

Collaborator

American Academy of Otolaryngology-Head and Neck Surgery Foundation

Collaborator